2017 | 02 | 16

Vironova is together with AstraZeneca part of a drug delivery technology Industrial Research Centre which has received 75M SEK from the Swedish foundation for Strategic Research (SSF).

At Vironova we are proud about being part of this new FoRmulaEx centre that has been recognized by SSF to meet the highest international scientific standards. The FoRmulaEx centre will develop methods for efficient and robust delivery of complex, oligonucleotide drugs. Our participation is an endorsement of our leading position in enabling electron microscopy technologies that help to speed up product development and secure final product quality in the pharmaceutical industry.

News and events

Read about the latest news and events at Vironova.

  • All news
  • Inside Vironova
  • Open positions
  • Events and publications

Upcoming events 2017

Bioprocess International & Cell and gene therapy bioprocessing
September 25-28 in Boston

  • Exhibition of MiniTEM
  • Technology workshop Tuesday September 26, at 11:50am - 12:20pm
  • Title: Meaningful insights on sub-visible particle morphology, size and purity
  • Speaker: Mathieu Colomb-Delsuc, Senior Scientist

Upcoming webinar October 18

  • Title: MiniTEM Analysis of Viral Vector Particles Provides Insight in Shorter Turnaround Time as Compared to Traditional Assays
  • Speaker: Josefina Nilsson, head of EM services
  • Register here

Vironova on MyNewsDesk

Follow us on MyNewsDesk and get the latest info on investor relations, events and company news.
Click here to get to our MyNewsDesk-page.

Press contact
For press enquiries, please contact

IR contact
Mohammed Homman